Best Life Sciences Companies in Russia
The 92 best Life Sciences companies in Russia in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: TREKPOR TECHNOLOGY.
Life Sciences funding in Russia is thin but moving: 92 companies tracked, $69M in total disclosed capital, zero unicorns, and one name eating most of the room. Trekpor Technology has pulled in $43M, which dwarfs everything else on the list. Incuron sits at $6M, TheraMAB at $5M, and the rest cluster well below that. So what's actually drawing investor attention here? Hot themes are stem cell banking, cell-based therapies, diagnostic biotechnology, and gene delivery systems, and backers like Maxwell Biotech Group, RVC USA, and Rusnano are the ones writing the checks. Globally, the sector is tracking toward a market built on 10.2% CAGR growth, with aging populations and sustained funding pressure as the main drivers.
I'd watch the digital health signal too. Median install growth across life and health science apps is running at roughly +43% YoY, which tells you demand is real even where capital is sparse. Globally, moves like Sai Life Sciences' planned IPO and Asahi Songwon's API acquisition signal that the broader sector is consolidating fast. Russia's slice of that story is early-stage, concentrated, and worth tracking if you care where the next wave of biotech capital lands.
- Morgan Stanley Ups the Ante on These 2 Life Science Tool Stocks
Our analysis of 576 Life Sciences companies
$91.7b in tracked funding; 70% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Russia
| # | Company | Disclosed funding | Last round | Stage | Founder | Employees | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Advanced Technologies Center Provider of scanning probe microscope and software | — | — | Unfunded | Igor Yaminsky Founder | — | — | — | — |
| 2 | AGCT Provider of cell and gene therapeutics for HIV and cancer | — | — | Deadpooled | Marina Popova Co-Founder & CEO | — | — | — | — |
| 3 | Alkor Bio Manufacture of diagnostics kits, ELISA reagents and kits, and immunoassay instruments for molecular… | — | — | Deadpooled | Polyntsev Dmitry Genrihovich President & CEO | — | — | — | — |
| 4 | AppScience Provider of quality management system for pharmaceutical suppliers and manufacturers | — | — | Unfunded | Igor Yaremenko Co-Founder | — | TildaCloudflarecdnjs+7 | — | — |
| 5 | Assisted Surgical Technologies Developer of robotic surgery technology designed on bringing abdominal surgery and healthcare rehabilitation. | — | — | Deadpooled | — | 30 | — | — | — |
| 6 | Association of Medicine and Analytics Developer of diagnostics for Helicobacter pylori | — | — | Unfunded | Marina Dmitrienko CEO | — | TildaJivoChatPreact+4 | — | — |
| 7 | Atlas Provider of genetic testing services | — | — | Funding Raised | Sergey Musienko Co-Founder & CEO | — | Cart FunctionalitySentryNode.js+29 | 4 patents Patents concentrated in computing, sensing & instrumentation | — |
| 8 | Baby Token Provider of mobile app for tracking pregnancy | — | — | Deadpooled | Evgeniy Zhiharev Founder & CEO | — | — | — | — |
Top 12 Life Sciences companies in Russia
#1
Seed · Russia · founded 2005 · 5 employees$2Mraised▾
Developer of antiviral therapeutics to treat cancer and infectious diseases. The company has designed proprietary compounds to stop HPV infections early before progression and to treat cancers and pre-malignant infections caused by HPV.
- Mar 2025Grant (prize money)$2M
- Jan 2025Grant (prize money)$272.9K
- May 2023Grant (prize money)$2M
- Sep 2022Grant (prize money)—
#2
Public · Moscow, Moscow · founded 2015 · 117 employees$4.1Mraised▾
Provider of 3D-printed prosthetics. It has developed a myoelectric hand prosthesis. The company develops prosthetics upper limb and has created an active traction hand prosthesis that can restore the functionality of the grip in the case of complex partial injury.
- Dec 2024Conventional Debt$998.7K
- Jan 2021Series A$4.1M
#3
Series B · Dubna, Moscow Oblast · founded 1998$43Mraised▾
Developer of track-etched membrane for plasmapheresis and to cascade plasma filtration
#4
Series A · Moscow, Moscow · founded 2013 · 7 employees$3.5Mraised▾
ARNA Genomics is a medical data analysis and management platform that helps researchers gather, store, and analyze drug trial data, especially of those that are used to treat cancer. Uses blockchain technology to create a repository of cancer detection and treatment information. ARNA Panacea enables researchers to maintain their lab notes on the blockchain, complete with timestamp and ownership details etched into it. This allows for cross-country collaboration between researchers easier and cheaper.
- Sep 2020Series A$3.5M
#5
Deadpooled · Moscow, Moscow · founded 2009$5.7Mraised▾
Incuron is engaged in developing a pipeline of drugs to treat oncology. Two molecules currently undergoing clinical development are CBL0102 and CBL0137. CBL0102 is structurally identical to an old antimalarial drug, quinacrine, widely used for the treatment and prophylaxis of malaria. CBL0102 is a potent inducer of p53 and inhibitor of NF-kB via FACT-suppressing activity which gives its anti-cancer properties. This led to the finding that CBL0102 is toxic to multiple types of cancer cells in vitro and in some mouse models of cancer. However peculiar bio-distribution of CBL0102 in vivo with maximal accumulation in liver and skin suggested its clinical use against cancers located in liver and skin (primary and metastatic).
- Sep 2011Grant (prize money)$5M
- Nov 2010Grant (prize money)$244.5K
- Series A$5.7M
#6
Deadpooled · Moscow, Moscow · founded 2009 · 4 employees$5Mraised▾
TheraMAB develops immunotherapeutic monoclonal antibodies (MAbs). These MAbs modulate the activity of T-lymphocytes and may provide new treatment options for diseases in the field of autoimmunity and cancer. Its pipeline product TAB08 is a humanized IgG4 monoclonal antibody specific for the human T-lymphocyte co-stimulatory receptor CD28 which is described as agonistic T-cells stimulation. TheraMAB was founded by the investment fund Bioprocess Capital Ventures and was granted $5M from Skolkovos Innovation Center.
- Feb 2012Grant (prize money)$5M
#7
Seed · Saint Petersburg, Northwestern Federal District · founded 2017 · 4 employees$1.4Mraised▾
Provider of diagnosis and treatment device for Gastrointestinal and Hepato-Biliary system. Its product ISYCATH Enables selective collection of specific diagnostic material (e.g. bile, pancreatic juice) for research and diagnostic use. It also evacuates biofluids and contents from an isolated area of the gastrointestinal tract to prevent and treat acute inflammatory and perforating conditions.
- Dec 2020Seed$1.4M
#8
Seed · Moscow, Moscow · founded 2010 · 65 employees$2.4Mraised▾
Genotek provides direct-to-consumer genomic tests. Customers can order a kit online, mail in their cheek swab and receive results that have been signed off by doctors and genetic counselors. Genotek can test for over 5000 genes and screen for 4500 inherited conditions.
- 2016Angel$2M
- 2013Seed$400K
#9
Seed · Moscow, Moscow · founded 2018$332.8Kraised▾
Openface has developed personalized serum based on the skin health of the individuals. The company uses the genetics, lifestyle, eating habits and other health data through an online test to identify skin health conditions. The company analyses the answers to the questions provided in the test to develop personalized serum-based skin health products for treating skin problems such as acne, oily sheen, enlarged pores, age-related changes and others.
- Mar 2022Seed$332.8K
#10
Deadpooled · Moscow, Moscow · founded 2010 · 1 employees$1Mraised▾
OncoMax is focussed on developing drugs for range of cancers. It is developing its lead candidate OM-RCA-01, a monoclonal antibody (MAb) that binds to the extracellular domains of Fibroblast Growth Factor Receptor 1(FGFR1) and prevents receptor interaction with fibroblast growth factors thus inhibiting signal transduction. This inhibition claims to possess antitumor activity. The candidate is currently completing the preclinical research and is being developed for luminal B subtype of breast cancer, renal cell carcinoma, squamous cell carcinoma of the Lung and metastatic prostate cancer. It is currently conducting additional studies necessary to complete a registration dossier and access the first phase of clinical study.
- Dec 2011Seed—
- Dec 2011Grant (prize money)$1M
#11
Deadpooled · Moscow, Moscow · founded 2012 · 9 employees$530Kraised▾
Aiming for the clinical next-gen sequencing market iBinom launched a human genome interpretation service. iBinom Saas platform is an end-to-end genome interpretation solution for diagnostics of Mendelian and non-Mendelian diseases, tumor profiling, and drug response biomarker discovery studies. iBinom uses Amazon EC2, proprietary algorithms, machine learning technology and special design of medical report to make inherited disease diagnostics simpler and faster.
- Oct 2013Seed$100K
- May 2013Seed$130K
#12
Seed · Moscow, Moscow · founded 2017$72.1Kraised▾
Provider of a genetic test for detection of cancer. The tests analyze various specific genes that protect us from cancer, for the presence of mutations, and determine the risk of disease. The test also helps in personalized treatment.
- Jun 2018Seed$72.1K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in Russia
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 731 Russia-affiliated papers.
- Lomonosov Moscow State University35
- Ministry of Health25
- Bioengineering Center24
- Institute of Bioorganic Chemistry24
- Sechenov University23
- Gene2→12
- Gene expression1→5
- Population1→10
- Biomass (ecology)1→8
- Gene silencing1→7
- Drug1→4
- In vivo4→5
- Agriculture9
- Genetic diversity7
- Microbiome7
- Antibiotic resistance6
- Genome6
Where biotechnology is researched across Russia
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.